Research Summary
Analyzed using Evidence Intelligence™

UDCA may improve maternal cardiac function in gestational diabetes

Last updated August 18, 2026

Key finding

UDCA treatment was associated with more negative left atrial strain during atrial contraction (p = 0.016).

UDCA treatment compared to placebo in women with gestational diabetes.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

UDCA treatment compared to placebo in women with gestational diabetes.

Clinical relevance

This study evaluated UDCA treatment compared to placebo in women with gestational diabetes.

Keep in mind

Limitations were not clearly described in the extracted text.

Published in

Journal Reference

Publication details and source links for this paper.

Ana MCC, Jose EB, Christos C, et al. Effects of Ursodeoxycholic Acid on Maternal Cardiac Function in Gestational Diabetes Mellitus: A Randomized Controlled Trial. Journal of Clinical Medicine. 2026;15(2). doi:10.3390/jcm15020786

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Ursodeoxycholic acid and Left atrial contractile strain (LASct_AC), Left atrial reservoir strain (LASr_ED).

Primary intervention

Ursodeoxycholic acid

Primary outcomes

  • Left atrial contractile strain (LASct_AC)
  • Left atrial reservoir strain (LASr_ED)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

2
Evidence pairs
2
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Limited contributionModerate confidenceNetwork score: 42

0

Related topics

2

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 2 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Left atrial contractile strain (LASct_AC)

Ursodeoxycholic acid → Left atrial contractile strain (LASct_AC)

Ursodeoxycholic acid → Left atrial contractile strain (LASct_AC)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Left atrial reservoir strain (LASr_ED)

Ursodeoxycholic acid → Left atrial reservoir strain (LASr_ED)

Ursodeoxycholic acid → Left atrial reservoir strain (LASr_ED)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Omega-3 Fatty Acid Supplements and Left atrial contractile strain (LASct_AC), Omega-3 Fatty Acid Supplements and Left atrial reservoir strain (LASr_ED).

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Ursodeoxycholic acid improve left atrial reservoir strain (lasr_ed)?

Emerging Evidence

Ursodeoxycholic acid appears to improve Left atrial reservoir strain (LASr_ED).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Left atrial reservoir strain (LASr_ED)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Ursodeoxycholic acid improve left atrial contractile strain (lasct_ac)?

Emerging Evidence

Ursodeoxycholic acid may worsen Left atrial contractile strain (LASct_AC) or be associated with harm.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Left atrial contractile strain (LASct_AC)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.